OpenFilings
Akero Therapeutics, Inc.
Form
8-K
Report Period
2024-03-12
Date Filed
2024-03-18
Time Filed
16:31:02
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
8-K
EX-4.1
Filing on SEC Edgar